An International Journal of Otorhinolaryngology Clinics

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  15 (2023)
Volume  14 (2022)
Volume  13 (2021)
Volume  12 (2020)
Volume  11 (2019)
Volume  10 (2018)
Volume  9 (2017)
Volume  8 (2016)
Volume  7 (2015)
Volume  6 (2014)
Volume  5 (2013)
Volume  4 (2012)
Volume  3 (2011)
Volume  2 (2010)
Volume  1 (2009)
Related articles

VOLUME 6 , ISSUE 1 ( Number, 2014 ) > List of Articles

REVIEW ARTICLE

Impact of Bethesda System of Reporting for Thyroid Cytopathology

Varsha Dhume, Vikas Kavishwar

Keywords : Thyroid FNAC,Bethesda,AUS,Follicular neoplasm

Citation Information : Dhume V, Kavishwar V. Impact of Bethesda System of Reporting for Thyroid Cytopathology. Int J Otorhinolaryngol Clin 2014; 6 (1):15-22.

DOI: 10.5005/jp-journals-10003-1145

Published Online: 01-08-2014

Copyright Statement:  Copyright © 2014; The Author(s).


Abstract

How to cite this article

Dhume V, Kavishwar V. Impact of Bethesda System of Reporting for Thyroid Cytopathology. Int J Otorhinolaryngol Clin 2014;6(1):15-22.

PDF Share
  1. The Bethesda system for reporting thyroid cytopathology: a five-year retrospective review of one center experience. Int J Health Sci, Qassim Univ 6(2).
  2. The role of Thyroid fine needle aspiration cytology and the Bethesda system for reporting thyroid cytopathology. Diagnostic Histopathology 2011;17:95–105.
  3. Unsatisfactory (vs. nondiagnostic) thyroidal aspirates: a semantic issue? Diagn Cytopathol 2006;34(2):87–88.
  4. Techniques for thyroid FNA: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008;36(6):407–424.
  5. The clinical and diagnostic impact of using standard criteria of adequacy assessment and diagnostic terminology on thyroid nodule fine needle aspiration. Diagn Cytopathol 2008;36(3):161–166.
  6. Evidence-based criteria for adequacy in thyroid fine-needle aspiration. Am J Clin Pathol 2002;118(4):518–521.
  7. Follicular neoplasms of the thyroid. Decision tree approach using morphologic and morphometric parameters. Acta Cytol 1997;41(2):369–376.
  8. Techniques for thyroid FNA: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008;36(6):407–424.
  9. Recommendations for the management of cystic thyroid nodules. ANZ J Surg 2005;75(7):537–541.
  10. Fine-needle aspiration biopsy cytology of the thyroid. Its value and limitations in the diagnosis and management of solitary thyroid nodules. Pathol Annu 1991;26(Pt 1):63–91.
  11. Value of repeating a nondiagnostic thyroid fine-needle aspiration biopsy. Endocr Pract 2007;13(7):735–742.
  12. Assessment of nondiagnostic ultrasoundguided fine needle aspirations of thyroid nodules. J Clin Endocrinol Metab 2002;87(11):4924–4927.
  13. Nondiagnostic fine needle aspiration biopsy of the thyroid gland: a diagnostic dilemma. Acta Cytol 1996;40(3):423–428.
  14. Nondiagnostic thyroid fine needle aspiration cytology: outcome in surgical treatment. Rev Invest Clin 2007;59(3):180–183.
  15. Fine-needle aspiration cytology of the thyroid: a 12-year experience with 11, 000 biopsies. Clin Lab Med 1993;13:699–709.
  16. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Int Med 1993;118:282–289.
  17. The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation. Cyto J 2008;5(6).
  18. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008;36(6):425–437.
  19. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer 2007;111(6):508–516.
  20. Long-term follow-up of patients with benign thyroid fine needle aspiration cytologic diagnoses. Surgery 1989;106:980–985.
  21. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer 2007;111(5):306–315.
  22. Accuracy of thyroid fine-needle aspiration using receiver operator characteristic curves. Am J Clin Pathol 2001;116:477–482.
  23. Focal features of papillary carcinoma of the thyroid in fine-needle aspiration material are strongly associated with papillary carcinoma at resection. Am J Clin Pathol 2002;118(2):208–210.
  24. Atypical epithelial cells, cannot exclude papillary carcinoma, in fine needle aspiration of the thyroid. Acta Cytol 2008;52(3):320–324.
  25. Thyroid nodules with FNA cytology suspicious for follicular variant of papillary thyroid carcinoma: follow-up and management. Diagn Cytopathol 2000;23(6):380–385.
  26. Post-thyroid FNA testing and treatment options: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008;36(6):442–448.
  27. Diagnosis of “follicular neoplasm”: a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 2002;26(1):41–44.
  28. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer 2007;111(5):306–315.
  29. Factors that predict malignant thyroid lesions when fine-needle aspiration is ‘suspicious for follicular neoplasm’. Mayo Clin Proc 1997;72(10):913–916.
  30. Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens. Thyroid 2001;11(3):271–277.
  31. Interobserver agreement on microfollicles in thyroid fine-needle aspirates. Arch Pathol Lab Med 2006;130(2):148–152.
  32. How does one separate cellular follicular lesions of the thyroid by fine-needle aspiration biopsy? Diagn Cytopathol 1988;4:78–81.
  33. Interobserver variability in thyroid fine-needle aspiration interpretation of lesions showing predominantly colloid and follicular groups. Am J Clin Pathol 2005;124(2):239–244.
  34. Implications of follicular neoplasms, atypia and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules. Ann Surg 2002;235(5):656–662.
  35. et al. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 2006;12(1):63–102.
  36. Hurthle cell carcinoma is a better gold standard than Hurthle cell neoplasm for fine-needle aspiration of the thyroid: defining more consistent and specific cytologic criteria. Cancer 2002;96(5):261–266.
  37. Fine-needle aspiration cytology of Hurthle cell carcinoma of the thyroid. Diagn Cytopathol 2008;36(3):149–154.
  38. Reporting thyroid fine-needle aspiration: Literature review and a proposal. Diagn Cytopathol 2006;34(1):67–76.
  39. Contribution of intraoperative pathology evaluation to surgical management of thyroid nodules. Endocrinol Metab Clin North Am 1990;19(3):509–522.
  40. The accuracy of fine-needle aspiration biopsy and frozen section in patients with thyroid cancer. Thyroid 2002;12(7):619–626.
  41. Fine-needle aspiration cytology of the thyroid: a 12-year experience with 11,000 biopsies. Clin Lab Med 1993;13:699–709.
  42. Fine-needle aspiration of the macrofollicular and microfollicular subtypes of the follicular variant of papillary carcinoma of the thyroid. Cancer 1998;84(4):235–244.
  43. Follicular variant of papillary carcinoma. Cytologic and histologic correlation. Am J Clin Pathol 1999;111(2):216–222.
  44. The Bethesda system for reporting thyroid fine needle aspirates: a cytologic study with histologic follow-up. J Cytol 2013 Apr-Jun;30(2):94–99.
  45. The Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol 2009;132:658–665.
  46. Implications of the proposed thyroid fine-needle aspiration category of ‘follicular lesion of undetermined significance’: a 5-year multiinstitutional analysis. Diagn Cytopathol 2009;37:710–714.
  47. Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies. Am J Gastroenterol 2008;103:2333–2341.
  48. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008;36:425–437.
  49. Diagnostic criteria and risk-adapted approach to indeterminate thyroid cytodiagnosis. Cancer (Cancer Cytopathol) 2010;118:415–422.
  50. Fine-needle aspiration of follicular patterned lesions of the thyroid: diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations. Diagn Cytopathol 2010;38:731–739.
  51. Minimizing the diagnosis of ‘follicular lesion of undetermined significance’ and identifying predictive features for neoplasia. Diagn Cytopathol (published online ahead of print October 14, 2010).
  52. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol 2010;134:450–456.
  53. Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status. J Clin Endocrinol Metab 2011;96:658–664.
  54. Implications of the proposed thyroid fine-needle aspiration category of ‘follicular lesion of undetermined significance’: a 5-year multi-institutional analysis. Diagn Cytopathol 2009;37:710–714.
  55. Evidence-based evaluation of the risks of malignancy predicted by thyroid fine needle aspiration biopsies. Diagn Cytopathol 2010;38:252–259.
  56. The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer (Cancer Cytopathol) 2009;117:195–202.
  57. Contribution of molecular testing to thyroid fine-needle aspiration cytology of ‘follicular lesion of undetermined significance/atypia of undetermined significance.’ Cancer (Cancer Cytopathol) 2010;118:17–23.
  58. Effect of the Bethesda system for reporting thyroid cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions. Surgery 2010;148:1267–1272.
  59. Should ‘atypical follicular cells’ in thyroid fineneedle aspirates be subclassified? Cancer (Cancer Cytopathol) 2010;118:186–189.
  60. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid 2009;19:1215–1223.
  61. Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated FNA be the preferred initial approach? Am J Clin Pathol 2011;135:770–775.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.